Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Human (2)
- Priority journal (2)
- ABC transporter B5 (1)
- Alloantigen (1)
- Allogeneic stem cell transplantation (1)
-
- Alzheimer disease (1)
- Article (1)
- Article; blood (1)
- Biological marker (1)
- Blood sampling (1)
- Bone (1)
- Cell subpopulation (1)
- Cerebrospinal fluid (1)
- Com-position (1)
- Dementia (1)
- Geriatric patient (1)
- Graft survival (1)
- Heart transplantation (1)
- Immune evasion (1)
- Immunoregulation (1)
- Immunoregulatory dermal cell (1)
- Immunotherapy (1)
- In vivo study (1)
- Laboratory test (1)
- Lymphocyte proliferation (1)
- Major histocompatibility complex (1)
- Method (1)
- Muscle (1)
- Neuroimaging (1)
- Practice guideline (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Arterial Or Venous: Where Are The Circulating Tumor Cells?, Elin S. Gray
Arterial Or Venous: Where Are The Circulating Tumor Cells?, Elin S. Gray
Research outputs 2014 to 2021
The study of circulating tumor cells (CTCs) has been largely confounded by the low number of these cells in the blood stream amid billions of other cells. To overcome this challenge numerous methodologies for CTC isolation have been described. Photoacoustic flow cytometry (Nedosekin et al., 2013), dielectrophoresis array (Maltoni et al., 2015) and microfluidics (Warkiani et al., 2015) are among the most sophisticated of these methodologies. However, methods based on immunecapture and immunestaining are still the more frequently utilized, with CellSearch® remaining the most commonly used method to date and the only US FDA approved (Alix-Panabieres and Pantel, 2014). Irrespective …
Segmental Musculoskeletal Examinations Using Dual-Energy X-Ray Absorptiometry (Dxa): Positioning And Analysis Considerations, Nicolas H. Hart, Sophia Nimphius, Tania Spiteri, Jodie L. Cochrane, Robert U. Newton
Segmental Musculoskeletal Examinations Using Dual-Energy X-Ray Absorptiometry (Dxa): Positioning And Analysis Considerations, Nicolas H. Hart, Sophia Nimphius, Tania Spiteri, Jodie L. Cochrane, Robert U. Newton
Research outputs 2014 to 2021
Musculoskeletal examinations provide informative and valuable quantitative insight into muscle and bone health. DXA is one mainstream tool used to accurately and reliably determine body composition components and bone mass characteristics in-vivo. Presently, whole body scan models separate the body into axial and appendicular regions, however there is a need for localised appendicular segmentation models to further examine regions of interest within the upper and lower extremities. Similarly, in-consistencies pertaining to patient positioning exist in the litera-ture which influence measurement precision and analysis out-comes highlighting a need for standardised procedure. This paper provides standardised and reproducible: 1) positioning and analysis …
Abcb5 Identifies Immunoregulatory Dermal Cells, Tobias Schatton, Jun Yang, Sonja Kleffel, Mayuko Uehara, Steven R. Barthel, Christoph Schlapbach, Qian Zhan, Stephen Dudeney, Hansgeorg Mueller, Nayoung Lee, Juliane C. De Vries, Barbara Meier, Seppe Vander Beken, Mark M. Kluth, Christoph Ganss, Arlene H. Sharpe, Ana Maria Waaga-Gasser, Mohamed H. Sayegh, Reza Abdi, Karin Scharffetter-Kochanek, George F. Murphy, Thomas S. Kupper, Natasha Y. Frank, Markus H. Frank
Abcb5 Identifies Immunoregulatory Dermal Cells, Tobias Schatton, Jun Yang, Sonja Kleffel, Mayuko Uehara, Steven R. Barthel, Christoph Schlapbach, Qian Zhan, Stephen Dudeney, Hansgeorg Mueller, Nayoung Lee, Juliane C. De Vries, Barbara Meier, Seppe Vander Beken, Mark M. Kluth, Christoph Ganss, Arlene H. Sharpe, Ana Maria Waaga-Gasser, Mohamed H. Sayegh, Reza Abdi, Karin Scharffetter-Kochanek, George F. Murphy, Thomas S. Kupper, Natasha Y. Frank, Markus H. Frank
Research outputs 2014 to 2021
Cell-based strategies represent a new frontier in the treatment of immune-mediated disorders. However, the paucity of markers for isolation of molecularly defined immunomodulatory cell populations poses a barrier to this field. Here, we show that ATP-binding cassette member B5 (ABCB5) identifies dermal immunoregulatory cells (DIRCs) capable of exerting therapeutic immunoregulatory functions through engagement of programmed cell death 1 (PD-1). Purified Abcb5+ DIRCs suppressed T cell proliferation, evaded immune rejection, homed to recipient immune tissues, and induced Tregs in vivo. In fully major-histocompatibility-complex-mismatched cardiac allotransplantation models, allogeneic DIRCs significantly prolonged allograft survival. Blockade of DIRC-expressed PD-1 reversed the inhibitory effects of …
Guidelines For The Standardization Of Preanalytic Variables For Blood-Based Biomarker Studies In Alzheimer's Disease Research, Sid O'Bryant, Veer Gupta, Kim Henriksen, Melissa Edwards, Andreas Jeromin, Simone Lista, Chantal Bazenet, Holly Soares, Simon Lovestone, Harald Hampel, Thomas Montine, Kaj Blennow, Tatiana Foroud, Maria Carrillo, Neill Graff-Radford, Christoph Laske, Monique Breteler, Leslie Shaw, John Q. Trojanowski, Nicole Schupf, Robert A. Rissman, Anne M. Fagan, Pankaj Oberoi, Robert Umek, Michael W. Weiner, Paula Grammas, Holly Posner, Ralph Martins
Guidelines For The Standardization Of Preanalytic Variables For Blood-Based Biomarker Studies In Alzheimer's Disease Research, Sid O'Bryant, Veer Gupta, Kim Henriksen, Melissa Edwards, Andreas Jeromin, Simone Lista, Chantal Bazenet, Holly Soares, Simon Lovestone, Harald Hampel, Thomas Montine, Kaj Blennow, Tatiana Foroud, Maria Carrillo, Neill Graff-Radford, Christoph Laske, Monique Breteler, Leslie Shaw, John Q. Trojanowski, Nicole Schupf, Robert A. Rissman, Anne M. Fagan, Pankaj Oberoi, Robert Umek, Michael W. Weiner, Paula Grammas, Holly Posner, Ralph Martins
Research outputs 2014 to 2021
The lack of readily available biomarkers is a significant hindrance toward progressing to effective therapeutic and preventative strategies for Alzheimer's disease (AD). Blood-based biomarkers have potential to overcome access and cost barriers and greatly facilitate advanced neuroimaging and cerebrospinal fluid biomarker approaches. Despite the fact that preanalytical processing is the largest source of variability in laboratory testing, there are no currently available standardized preanalytical guidelines. The current international working group provides the initial starting point for such guidelines for standardized operating procedures (SOPs). It is anticipated that these guidelines will be updated as additional research findings become available. The statement …